Ask The Pharmacist: Bird Flu and Its Growing Impact on Public Health
3 MIN READ
Bird flu, or avian influenza, is an emerging public health and industry concern across North America. While the virus primarily affects birds, it can occasionally spread to humans—raising important questions around occupational exposure and public health safety.
Specialty Solutions Spotlight: Electronic Medical Records Streamline Recovery and Strengthen Claims Oversight
2 MIN READ
Electronic Medical Records (EMRs) are digital versions of traditional paper medical charts, offering real-time, secure access to patient information for authorized users. By streamlining access to clinical data and enhancing provider communication, EMRs are transforming how care is coordinated and delivered across the health care industry.
Ask The Pharmacist: FDA Approval of Non-Opioid Medication for Acute Pain
3 MIN READ
The U.S. Food and Drug Administration (FDA) recently approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate to severe acute pain in adults. This approval, announced on January 30, 2025, marks a significant milestone in pain management, introducing the first new class of oral medication for acute pain in over two decades.
10 Ways Field Case Management Can Make a Difference
4 MIN READ
Enlyte's field case management provides empathetic, innovative support for injured employees, guiding recovery with tailored solutions. Discover how our comprehensive approach can enhance your workers' compensation outcomes.
Specialty Solutions Spotlight: The Critical Role of Quality Clinical Documentation in Workers' Comp
2 MIN READ
In workers' compensation cases, timely and thorough clinical documentation is essential for effective case management and optimal injured employee outcomes. However, obtaining and reviewing these documents often presents significant challenges.
Ask The Pharmacist: Buprenorphine’s Role in Workers’ Compensation Pain Management
3 MIN READ
Buprenorphine, a Schedule III controlled substance approved by the U.S. Food and Drug Administration (FDA), is increasingly being considered for pain management in workers' compensation cases. This partial opioid agonist offers a unique profile that balances effective pain relief with a lower risk of abuse and dependence compared to full opioid agonists.
Long-Term Catastrophic Assessments
2 MIN READ
Enlyte offers Long-Term Catastrophic Assessments for workers' comp claims. Our comprehensive evaluations help manage complex cases, prevent complications, and ensure proper care.